INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 459m ago
House PTR59m ago
SEC 13F58m ago
Robinhood Chain58m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$402K
435 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$535K
580 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$468K
505 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$520K
560 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$256K
276 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$250K
272 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$292K
316 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$271K
295 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

42
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$270K
291 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

41
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Open-market sale
SELL$400K
6,667 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

39
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$167K
178 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$192K
208 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$81K
87 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$56K
60 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$126K
136 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$71K
76 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$115K
124 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$155K
167 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$241K
262 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$135K
146 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$172K
187 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$133K
144 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$233K
252 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

36
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$9,360
10 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

36
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$11K
12 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

36
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$37K
40 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

36
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$375K
79.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

34
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$81K
842 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

33
BK
Banks Margaret KatherineDirector
HALHALLIBURTON CO
Open-market sale
SELL$89K
2,600 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

32
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$423K
89.1K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

30
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Open-market sale
SELL$63K
1,048 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

30
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$718K
2,600 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

25
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$110K
23.8K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

25
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$124K
26.9K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

24
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$74K
263 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

23
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$64K
227 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$144K
524 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$117K
421 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$119K
429 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

Page 356 of 481
← PrevNext →